8 Targeted Protein Degradation conferences in 2023 you won’t want to miss
NanoTemper Technologies announces Monolith X with breakthrough Spectral Shift technology, enabling binding affinity measurements where other methods fail
10 terms to help you more easily understand targeted protein degradation
For protein degraders to tackle neurodegenerative diseases, these are the barriers they need to overcome
Why so many companies are betting on PROTACs as a superior therapeutic modality
NanoTemper’s Monolith wins top global design award: Red Dot Award
Protein degraders show promising results in drug development pipelines. See progress candidates have made.
NanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021
Are you building an effective protein degrader? 4 questions to ask yourself to find out
